Mucus Relief Cold and Sinus

Product NDC
55910-033
11-digit product format
559100033
Labeler code
55910
Product ID
55910-033_66e4807c-3e92-44d7-b586-d31b41b3d2a9
Type
HUMAN OTC DRUG
Nonproprietary name
Acetaminophen, Guaifenesin, Phenylephrine HCl
Dosage form
LIQUID
Route
ORAL
Labeler
Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)
Application
part341
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2014-06-30
Marketing end
2025-01-31
Substance
ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
Active strength
650 mg/20mL; mg/20mL; mg/20mL
Pharmacologic classes
Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct55910-033DDiscontinued by firm2026-10-20
excluded packagepackage55910-03355910-033-09DDiscontinued by firm2026-10-20

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage55910-033-09d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage55910-033-09f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage55910-033-092ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage55910-033-09a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage55910-033-09cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage55910-033-09cdf11ea48f46…ba0047e9e063…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ACETAMINOPHENACTIVE INGREDIENT362O9ITL9DMUCUS RELIEF COLD AND SINUS MAXIMUM STRENGTH (ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]3
GUAIFENESINACTIVE INGREDIENT495W7451VQMUCUS RELIEF COLD AND SINUS MAXIMUM STRENGTH (ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]3
PHENYLEPHRINE HYDROCHLORIDEACTIVE INGREDIENT04JA59TNSJMUCUS RELIEF COLD AND SINUS MAXIMUM STRENGTH (ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]3
ACETAMINOPHENACTIVE MOIETY362O9ITL9DMUCUS RELIEF COLD AND SINUS MAXIMUM STRENGTH (ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]3
GUAIFENESINACTIVE MOIETY495W7451VQMUCUS RELIEF COLD AND SINUS MAXIMUM STRENGTH (ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]3
PHENYLEPHRINEACTIVE MOIETY1WS297W6MVMUCUS RELIEF COLD AND SINUS MAXIMUM STRENGTH (ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]3
ANHYDROUS CITRIC ACIDINACTIVE INGREDIENTXF417D3PSLMUCUS RELIEF COLD AND SINUS MAXIMUM STRENGTH (ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]3
EDETATE DISODIUMINACTIVE INGREDIENT7FLD91C86KMUCUS RELIEF COLD AND SINUS MAXIMUM STRENGTH (ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]3
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBDMUCUS RELIEF COLD AND SINUS MAXIMUM STRENGTH (ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]3
FD&C RED NO. 40INACTIVE INGREDIENTWZB9127XOAMUCUS RELIEF COLD AND SINUS MAXIMUM STRENGTH (ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]3
GLYCERININACTIVE INGREDIENTPDC6A3C0OXMUCUS RELIEF COLD AND SINUS MAXIMUM STRENGTH (ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]3
PROPYL GALLATEINACTIVE INGREDIENT8D4SNN7V92MUCUS RELIEF COLD AND SINUS MAXIMUM STRENGTH (ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]3
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3MUCUS RELIEF COLD AND SINUS MAXIMUM STRENGTH (ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]3
SODIUM BENZOATEINACTIVE INGREDIENTOJ245FE5EUMUCUS RELIEF COLD AND SINUS MAXIMUM STRENGTH (ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]3
SORBITOLINACTIVE INGREDIENT506T60A25RMUCUS RELIEF COLD AND SINUS MAXIMUM STRENGTH (ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]3
SUCRALOSEINACTIVE INGREDIENT96K6UQ3ZD4MUCUS RELIEF COLD AND SINUS MAXIMUM STRENGTH (ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]3
TRISODIUM CITRATE DIHYDRATEINACTIVE INGREDIENTB22547B95KMUCUS RELIEF COLD AND SINUS MAXIMUM STRENGTH (ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]3
WATERINACTIVE INGREDIENT059QF0KO0RMUCUS RELIEF COLD AND SINUS MAXIMUM STRENGTH (ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]3
XANTHAN GUMINACTIVE INGREDIENTTTV12P4NEEMUCUS RELIEF COLD AND SINUS MAXIMUM STRENGTH (ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL) LIQUID [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)]3

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
55910-033-0955910003309266 mL in 1 BOTTLE, PLASTIC (55910-033-09) 266 ml2014-06-300000-00-00NoNoCurrent